Results 81 to 90 of about 8,348 (154)

Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system. [PDF]

HIV Med
Zhang L, Chen L, Tang J, Liu X, Zheng L, Wang F, Huang X, Cao W, Li T.   +8 more
europepmc   +1 more source

Elimination of Human Immunodeficiency Virus Reservoirs Harboring Intact Proviruses. [PDF]

J Infect Dis
Li M, Truong K, Sharma S, Sun B, Chen M, Kimata JT, Wang J.   +6 more
europepmc   +1 more source

Association between plasma concentrations of integrase strand transfer inhibitors and body weight gain in women with HIV. [PDF]

AIDS
Lahiri CD, Soibi-Harry AP, Musonge-Effoe J, Alvarez JA, Dumond JB, Mehta CC, Yang Q, Sheth AN, Ofotokun I, Sykes C, Hartauer M, Khoei A, Alcaide ML, Rubin LH, Konkle-Parker D, Floris-Moore M, Topper EF, French AL, Cocohoba J, Kassaye S, Augenbraun M, Sharma A, Tien PC.   +22 more
europepmc   +1 more source

Therapeutic Approaches for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: Current and Emerging Strategies. [PDF]

Pathogens
Nakamura T, Satoh K.
europepmc   +1 more source

Efficacy of raltegravir in achieving virological suppression at delivery in HIV-positive pregnant women: a systematic review and meta-analysis. [PDF]

BMC Pregnancy Childbirth
Zhang Y, Wu W, Yang M, Liu J, Wu H, Chen Y.   +5 more
europepmc   +1 more source

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025. [PDF]

Euro Surveill
van Kampen J, Voermans J, Soochit W, Mesplède T, van de Laar T, van der Reijden W, Burger D, Shalev N, van Sighem A, Bezemer D, Jurriaans S, van der Vaart T, de Jong H, van der Valk M.   +13 more
europepmc   +1 more source

HIV-1 integrase resistance in the context of antiretroviral therapy in paediatric patients ‒ Northeast Brazil. [PDF]

Braz J Infect Dis
Luz AL, Leal É, Lima K, Souza MM, Silva MLC, Lima MM, Sette PGT, Almeida YLM, Melo HRL.   +8 more
europepmc   +1 more source

Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review. [PDF]

Int J Mol Sci
Gáspár Z, Lakatos B.
europepmc   +1 more source

Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study. [PDF]

J Exp Pharmacol
Rao AM, Sm F, Somashekara D, Gayam PKR, Rahangdale RR, Patil SS, Hariharapura RC.   +6 more
europepmc   +1 more source

Efavirenz-Induced Hepatitis Mimicking Autoimmune Hepatitis: A Case Report. [PDF]

Cureus
Chowdhury AH, Chowdhury D, Jahan I, Woghiren A, Saleh M.   +4 more
europepmc   +1 more source